QQQ   444.67 (-0.04%)
AAPL   170.70 (-1.51%)
MSFT   421.05 (-0.09%)
META   489.25 (-0.93%)
GOOGL   150.85 (-0.01%)
AMZN   180.85 (+0.57%)
TSLA   176.85 (-1.66%)
NVDA   908.44 (+0.66%)
NIO   4.61 (-1.28%)
AMD   181.43 (+1.02%)
BABA   72.45 (+1.20%)
T   17.57 (+0.11%)
F   13.24 (+1.38%)
MU   118.28 (-0.72%)
CGC   9.28 (-2.83%)
GE   175.02 (-2.83%)
DIS   122.68 (+1.41%)
AMC   3.75 (-13.59%)
PFE   27.91 (+0.47%)
PYPL   66.84 (+0.41%)
XOM   115.46 (+0.43%)
QQQ   444.67 (-0.04%)
AAPL   170.70 (-1.51%)
MSFT   421.05 (-0.09%)
META   489.25 (-0.93%)
GOOGL   150.85 (-0.01%)
AMZN   180.85 (+0.57%)
TSLA   176.85 (-1.66%)
NVDA   908.44 (+0.66%)
NIO   4.61 (-1.28%)
AMD   181.43 (+1.02%)
BABA   72.45 (+1.20%)
T   17.57 (+0.11%)
F   13.24 (+1.38%)
MU   118.28 (-0.72%)
CGC   9.28 (-2.83%)
GE   175.02 (-2.83%)
DIS   122.68 (+1.41%)
AMC   3.75 (-13.59%)
PFE   27.91 (+0.47%)
PYPL   66.84 (+0.41%)
XOM   115.46 (+0.43%)
QQQ   444.67 (-0.04%)
AAPL   170.70 (-1.51%)
MSFT   421.05 (-0.09%)
META   489.25 (-0.93%)
GOOGL   150.85 (-0.01%)
AMZN   180.85 (+0.57%)
TSLA   176.85 (-1.66%)
NVDA   908.44 (+0.66%)
NIO   4.61 (-1.28%)
AMD   181.43 (+1.02%)
BABA   72.45 (+1.20%)
T   17.57 (+0.11%)
F   13.24 (+1.38%)
MU   118.28 (-0.72%)
CGC   9.28 (-2.83%)
GE   175.02 (-2.83%)
DIS   122.68 (+1.41%)
AMC   3.75 (-13.59%)
PFE   27.91 (+0.47%)
PYPL   66.84 (+0.41%)
XOM   115.46 (+0.43%)
QQQ   444.67 (-0.04%)
AAPL   170.70 (-1.51%)
MSFT   421.05 (-0.09%)
META   489.25 (-0.93%)
GOOGL   150.85 (-0.01%)
AMZN   180.85 (+0.57%)
TSLA   176.85 (-1.66%)
NVDA   908.44 (+0.66%)
NIO   4.61 (-1.28%)
AMD   181.43 (+1.02%)
BABA   72.45 (+1.20%)
T   17.57 (+0.11%)
F   13.24 (+1.38%)
MU   118.28 (-0.72%)
CGC   9.28 (-2.83%)
GE   175.02 (-2.83%)
DIS   122.68 (+1.41%)
AMC   3.75 (-13.59%)
PFE   27.91 (+0.47%)
PYPL   66.84 (+0.41%)
XOM   115.46 (+0.43%)
NASDAQ:APM

Aptorum Group (APM) Stock Price, News & Analysis

$9.00
+0.30 (+3.45%)
(As of 11:16 AM ET)
Today's Range
$8.51
$9.30
50-Day Range
$1.39
$9.63
52-Week Range
$1.35
$17.49
Volume
69,827 shs
Average Volume
2.51 million shs
Market Capitalization
$32.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
APM stock logo

About Aptorum Group Stock (NASDAQ:APM)

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A. The company is also developing ALS-2/3 for the treatment of gram+ve bacterial infections; RPIDD, a pathogen molecular diagnostic; NativusWell DOI (NLS-2), a dietary supplement; NLS-1 for the treatment of endometriosis; DLS-1+2 to treat NSCLC with mutation; DLS-3, an autoimmune small molecule; and CLS-1 for the treatment of obesity. Its pipeline products enable the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platforms for treatment of metabolic diseases. The company also focuses on therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas. In addition, it operates a medical clinic. The company was formerly known as APTUS Holdings Limited and changed its name to Aptorum Group Limited in October 2017. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom. Aptorum Group Limited is a subsidiary of Jurchen Investment Corporation.

APM Stock Price History

APM Stock News Headlines

Aptorum Group Limited (APM)
Buy Friday, Sell Monday, No Exceptions
Every week traders grind it out Monday through Friday… But neglect trading Friday to Monday… Or… “over the weekend” As one professional trader explains, trading over the weekend is one of the most forgiving strategies you can use today. It allows him to sidestep a lot of the midweek volatility. Yet, gives him the opportunity to target some of the markets biggest stock moves. Just recently, he posted a trade on Nordstrom… The trade was published at 3pm on a Friday afternoon and by Monday morning the trade more than doubled.
Aptorum Group Limited Class A
5 Investors Betting Big on Aptorum (APM) Group
Why Is Aptorum (APM) Stock Up 346% Today?
Aptorum Group Ltd Class A (APM)
The AI Defense Stock Set to Soar
To protect our interests, The Pentagon has partnered with this small AI defense contractor - creating some of the most powerful AI defenses ever made.
Aptorum Group Cl A Share Chat
Aptorum Group GAAP EPS of -$1.43, revenue of $0.43M
Aptorum Group Ltd Class A APM
APM - Aptorum Group Limited
See More Headlines
Receive APM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aptorum Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
3/28/2024
Next Earnings (Estimated)
4/26/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:APM
Fax
N/A
Employees
18
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.30 million
Book Value
$2.19 per share

Miscellaneous

Free Float
1,286,000
Market Cap
$33.20 million
Optionable
Not Optionable
Beta
0.10
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Chung Yuen Huen (Age 44)
    Founder, CEO & Non-Executive Director
    Comp: $923.66k
  • Mr. Martin Siu (Age 45)
    Head of Finance
    Comp: $87.34k

APM Stock Analysis - Frequently Asked Questions

How have APM shares performed in 2024?

Aptorum Group's stock was trading at $2.45 on January 1st, 2024. Since then, APM shares have increased by 279.6% and is now trading at $9.30.
View the best growth stocks for 2024 here
.

Are investors shorting Aptorum Group?

Aptorum Group saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 128,900 shares, an increase of 42,866.7% from the February 29th total of 300 shares. Based on an average daily volume of 2,310,000 shares, the days-to-cover ratio is presently 0.1 days. Approximately 5.1% of the company's stock are short sold.
View Aptorum Group's Short Interest
.

When is Aptorum Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, April 26th 2024.
View our APM earnings forecast
.

When did Aptorum Group's stock split?

Shares of Aptorum Group reverse split before market open on Monday, January 23rd 2023. The 1-10 reverse split was announced on Monday, January 23rd 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, January 23rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What other stocks do shareholders of Aptorum Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aptorum Group investors own include Gilead Sciences (GILD), SCYNEXIS (SCYX), Cidara Therapeutics (CDTX), Quest Diagnostics (DGX), Dynavax Technologies (DVAX), Inovio Pharmaceuticals (INO), Micron Technology (MU), Aridis Pharmaceuticals (ARDS).

How do I buy shares of Aptorum Group?

Shares of APM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:APM) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners